2018
DOI: 10.1016/j.jaapos.2018.07.350
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative use of intravenous dexamethasone in the management of congenital nasolacrimal duct obstruction with balloon dacryoplasty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…To further increase the success of BD, Hussein and Lopez (2018) added the use of intravenous dexamethasone perioperatively (0.5 mg/kg) to achieve higher success for BD procedures in primary CNLDO. [ 31 ] They compared 71 eyes (61 children) in the steroid group and 18 eyes (13 patients) in the no-steroid group. The rationale was to minimize the procedure-related edema of NLD, leading to a better success rate.…”
Section: Discussionmentioning
confidence: 99%
“…To further increase the success of BD, Hussein and Lopez (2018) added the use of intravenous dexamethasone perioperatively (0.5 mg/kg) to achieve higher success for BD procedures in primary CNLDO. [ 31 ] They compared 71 eyes (61 children) in the steroid group and 18 eyes (13 patients) in the no-steroid group. The rationale was to minimize the procedure-related edema of NLD, leading to a better success rate.…”
Section: Discussionmentioning
confidence: 99%